Ethyl 1,3-dimethyl-1H-pyrazole-4-carboxylate, 95.0%, 5g

3-Methyl-4-nonanone, 97.0%, 1g

N-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-3-amine, 95.0%, 100mg

3-Bromophenanthrene, 95.0%, 5g

N-Boc-3-cyclopentylamino-propionic acid, 98.0%, 1g

(6-(Cyclopropylmethoxy)pyridin-3-yl)boronic acid, 95.0%, 1g

2-Hydroxy-4-methyl-5-nitro-benzaldehyde, 98%, 1g

1-(3-Chloro-2,6-difluorophenyl)ethanamine, 97%, 1g

(4-(4-(6-FLUOROBENZO[D]OXAZOL-2-YL)BENZOYL)PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE, 95%, 50mg

Diethylene Glycol Ethyl Methyl Ether>98.0%(GC)25mL

1-(2,2,2-Trifluoro-ethyl)-1 H -pyrazol-4-ylamine, 95.0%, 10g

GC capillary column ROTI®Cap-5 HT, 30 m, 0.32 mm, 0.10 µm, 1 Piece(s)

Naphthalene-1,4-dicarboxaldehyde, 98%, 10g